OR WAIT null SECS
October 01, 2024
Article
Subclinical atherosclerosis burden and its progression are independently linked to the risk of death from any cause in asymptomatic individuals.
September 27, 2024
Expert clinical consensus from the National Lipid Association finds ApoB testing is useful to stratify ASCVD risk more accurately than LDL-C.
The approval to GE Healthcare's cyclotron-produced radioactive diagnostic drug provides another option to adequately identify significant coronary artery disease.
September 25, 2024
A Q&A with Nihar Desai, MD, on the PROMPT-Lipid trial and the potential of advancing technology for improving patient care in pragmatic ways.
September 24, 2024
Video
HCPLive spoke to Johnson on how strategies for addressing patient misconceptions about cholesterol management.
At the Family Heart Summit, Nihar Desai, MD, discussed using EMR alerts to improve lipid therapy for high-risk ASCVD, as shown in the PROMPT-Lipid trial.
The analysis of LDL-C Management Trends observed disparities in LDL-C goal attainment by race, gender, and age.
September 17, 2024
A new study revealed those who consume a moderate amount of coffee or caffeine had a 48.1% and 40.7% reduced risk for developing cardiometabolic multimorbidity.
September 16, 2024
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key updates from the European Society of Cardiology (ESC) Congress 2024.
In this edition of the APAC Recap, Erin Pardee, PA-C, discusses the American Society of Preventive Cardiology 2024 Congress on CVD Prevention with Viet Le, DMSc, PA-C.
